跳至主要内容
临床试验/NCT02996279
NCT02996279已完成不适用

Impact of Chorioamnionitis on Maternal and Fetal Levels of Proinflammatory S100A12

Catholic University of the Sacred Heart0 个研究点目标入组 69 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
69
主要终点
S100A12 in Presence of Maternal Chorioamnionitis

研究概览

简要总结

Histologic chorioamnionitis (HCA) may lead to the fetal inflammatory response syndrome (FIRS) and increased levels of proinflammatory molecules.

详细描述

Histologic chorioamnionitis (HCA) may lead to the fetal inflammatory response syndrome (FIRS). The aim of this pilot study was to evaluate S100A12, a marker of innate immune activation, in mothers with or without HCA and in their infants.

Concentrations of S100A12, Interleukin 6 (IL-6) and C-reactive protein (CRP) were evaluated in maternal, cord, and neonatal blood of very preterm infants. Histologic examinations of placentae and umbilical cords were performed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Preterm Birth

排除标准

  • Congenital Abnormalities

结局指标

主要结局

S100A12 in Presence of Maternal Chorioamnionitis

时间窗: 1 Year

Levels of S100A12 in Maternal, Cord and Neonatal Blood in the Presence or Absence of HCA

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

MARIA PIA DE CAROLIS

MD

Catholic University of the Sacred Heart

相似试验